Aura Biosciences
Latest round
- Series E
Last raised
- Mar 2021
Total raised
- $153M
Investors
- 15
About Aura Biosciences
Aura Biosciences, Inc.Founded in 2009 in Boston, US, Aura Biosciences, Inc. specializes in innovative oncology treatments.Aura Biosciences develops targeted therapies in oncology, utilizing its Virus-Like Drug Conjugate (VDC) technology. Its leading product, Belzupacap sarotalocan, targets early-stage choroidal melanoma.Aura Biosciences generates revenue through partnerships with academic institutions and healthcare organizations, focusing on its VDC products.
Who invested in Aura Biosciences
15 investors across 4 rounds
See all investors in Aura Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aura Biosciences
Who invested in Aura Biosciences?
Aura Biosciences has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aura Biosciences raised?
Aura Biosciences has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Aura Biosciences last raise money?
Aura Biosciences's most recent round on record is a Series E, in Mar 2021.
What does Aura Biosciences do?
Aura Biosciences is a biotechnology company.
Where is Aura Biosciences headquartered?
Aura Biosciences is headquartered in Boston, US.
Which VCs invest in companies like Aura Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aura Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Aura Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.